Stock Information

• Revolution Medicines Begins Phase 3 Trial For Advanced Lung Cancer Treatment
  Tue, Oct 20, 2026 5:00 PM
• Revolution Medicines (RVMD) Has an Approved Cancer Drug. Can Its $38 Billion Valuation Deliver?
  Tue, Oct 20, 2026 4:34 PM
• Tango Therapeutics (TNGX) Has Striking Pancreatic Cancer Data. How Much Is Priced In?
  Tue, Oct 20, 2026 4:34 PM
• Incyte: Digesting The ESMO Updates In Pancreatic, Colorectal, And Ovarian Cancer
  Tue, Oct 20, 2026 2:40 PM
• Revolution Medicines Begins Treating Patients in Phase 3 RASolve 308 Trial Evaluating Zoldonrasib in Combination with Pembrolizumab and Chemotherapy as First-Line Treatment for Patients with Metastatic RAS G12D Non-Squamous Non-Small Cell Lung Cancer
  Tue, Oct 20, 2026 12:00 PM
• Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study
  Mon, Oct 19, 2026 1:14 PM
• Truist Securities Maintains Buy on Revolution Medicines, Raises Price Target to $241
  Mon, Oct 19, 2026 9:26 AM
• Revolution Medicines Stock In Focus After EU Drug Backing
  Sat, Oct 17, 2026 2:09 PM
• Revolution Medicines Stock Has Surged 124% This Year — Analyst Sees More Room to Grow
  Fri, Oct 16, 2026 1:06 PM
• William Blair Initiates Coverage On Revolution Medicines with Outperform Rating
  Fri, Oct 16, 2026 11:02 AM

Financial data not available